|Bid||0.0000 x 800|
|Ask||0.0000 x 1000|
|Day's range||4.6000 - 4.8299|
|52-week range||4.1200 - 10.7000|
|Beta (5Y monthly)||1.13|
|PE ratio (TTM)||N/A|
|Earnings date||24 Aug 2021 - 30 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||5.75|
Lannett (LCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
On Friday, investors were refusing the pill that is generic-drug specialist Lannett (NYSE: LCI). The company's shares took a painful hit, sinking by 13% after the company got the toss from a high-profile stock index. After market close Thursday S&P Dow Jones Indices, the company responsible for the closely followed S&P suite of securities indexes, announced a set of adjustments to three of its stock indicators.
LCI earnings call for the period ending March 31, 2021.